• Earlier in April 2026, IBM and partners announced a series of AI-, quantum-, and cybersecurity-focused collaborations and product launches, including an expanded IBM-Illinois Discovery Accelerator Institute, new AI-powered autonomous security services, healthcare causal-AI deployments with GNQ Insilico, and participation in the Shared AI License Foundation to ease access to AI patents.
• Together, these moves highlight IBM’s push to position its software, hybrid cloud, and quantum capabilities as shared infrastructure for enterprises, researchers, and healthcare providers, potentially deepening client integration with IBM’s platforms across critical workloads.
• We’ll now examine how IBM’s push into quantum-centric supercomputing and autonomous AI security could influence its existing investment narrative.

Uncover the next big thing with 29 elite penny stocks that balance risk and reward.

International Business Machines Investment Narrative Recap

To own IBM today, you need to believe its shift toward higher margin software, hybrid cloud, AI, and quantum can more than offset pressure on legacy mainframe and consulting lines, while supporting ongoing dividends and debt service. The latest AI, quantum, and security announcements may reinforce the near term growth catalyst in software and AI services, but they do not materially change the key risk that macro uncertainty or budget caution could still slow consulting and consumption based software demand.

Among April’s updates, the expansion of the IBM Illinois Discovery Accelerator Institute stands out for investors. It ties IBM’s quantum centric supercomputing vision directly into real world high performance computing workflows, reinforcing the longer term catalyst that IBM’s AI and quantum platforms may deepen integration with large enterprise and public sector clients. That said, it does not remove nearer term execution risks around monetizing these capabilities at scale.

Yet behind IBM’s AI and quantum story, a less visible risk that investors should be aware of is...

International Business Machines' narrative projects $74.4 billion revenue and $10.5 billion earnings by 2028. This implies 5.1% yearly revenue growth and about a $4.6 billion earnings increase from $5.9 billion today.

Uncover how International Business Machines' forecasts yield a $302.05 fair value, a 18% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts already expected IBM to reach about US$83.4 billion in revenue and US$14.3 billion in earnings by 2029, so if you buy into that view, the latest quantum and AI security moves might look like further support for a faster software led growth path, while others may still worry about legacy revenue erosion and see these same headlines as only a partial answer to that concern.

Explore 13 other fair value estimates on International Business Machines - why the stock might be worth 13% less than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your International Business Machines research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
• Our free International Business Machines research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate International Business Machines' overall financial health at a glance.

Looking For Alternative Opportunities?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• Invest in the nuclear renaissance through our list of 92 elite nuclear energy infrastructure plays powering the global AI revolution.
• The future of work is here. Discover the 35 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• We've uncovered the 13 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.